
U.S.-based Novavax begins clinical trial of COVID-19 vaccine in Australia
Novavax is developing the SARS-CoV-2 Recombinant Spike Protein Nanoparticle vaccine -- NVX-CoV2373.

Chinese researchers develop super-strong material for aerospace application
Chinese researchers develop super-strong material for aerospace applications
WHO suspends clinical trial with hydroxychloroquine on COVID-19 patients
clinical trial of malaria drug hydroxychloroquine on COVID-19 patients came to "a temporary pause".
China moves to further lower financing costs for enterprises
Chinese authorities have unveiled a guideline to further reduce financing costs for enterprises.